Skip to main content
Top
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Research

Association between STAT3 gene Polymorphisms and Crohn’s diseasesusceptibility: a case–control study in a Chinese Han population

Authors: Zhengting Wang, Bin Xu, Hongxin Zhang, Rong Fan, Jie Zhou, Jie Zhong

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Crohn’s disease (CD) is an immune-related disease with geneticpredisposition. This study aimed to investigate the association of threepolymorphisms in the signal transducer and activator of transcription 3(STAT3) gene with CD risk in a Chinese population.

Methods

We conducted a hospital-based case–control study involving 232 CDpatients and 272 controls. Genotyping was performed using polymerase chainreaction with sequence-specific primer method. Statistical analyses wereconducted using logistic regression and genotype risk scoring.

Results

Significant differences were found between patients and controls inallele/genotype distributions of rs744166(P allele = 0.0008;P genotype = 0.003) and allele distributions ofrs4796793 (P = 0.03). The risk for CD associated withthe rs744166-A mutant allele decreased by 37% [95% confidence interval (CI):0.48–0.83] under the additive model, 39% (95% CI: 0.43–0.81)under the dominant model and 57% (95% CI: 0.24–0.77) under therecessive model. Carriers of the rs4796793-G mutant allele exhibited 25%(95% CI: 0.58–0.98; P = 0.03) and 47% (95% CI:0.30–0.95) decreased risks of developing CD under the additive andrecessive models, respectively.

Conclusions

STAT3 rs744166 and rs4796793 polymorphisms may be associated with CDoccurrence and used as a predictive factor of CD in Chinese Hanpopulations.

Virtual Slides

Literature
1.
go back to reference Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG: Progress in searching for susceptibility gene for inflammatory bowel diseaseby positional cloning. World J Gastroenterol. 2003, 9 (8): 1646-1656.PubMedPubMedCentralCrossRef Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG: Progress in searching for susceptibility gene for inflammatory bowel diseaseby positional cloning. World J Gastroenterol. 2003, 9 (8): 1646-1656.PubMedPubMedCentralCrossRef
2.
go back to reference Molodecky NA, Kaplan GG: Environmental risk factors for inflammatory bowel disease. Gastroenterology hepatology(NY). 2010, 6 (5): 339-346. Molodecky NA, Kaplan GG: Environmental risk factors for inflammatory bowel disease. Gastroenterology hepatology(NY). 2010, 6 (5): 339-346.
3.
go back to reference Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008, 8 (6): 458-466. 10.1038/nri2340.PubMedCrossRef Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008, 8 (6): 458-466. 10.1038/nri2340.PubMedCrossRef
4.
go back to reference Murray PJ: The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007, 178 (5): 2623-2629. 10.4049/jimmunol.178.5.2623.PubMedCrossRef Murray PJ: The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007, 178 (5): 2623-2629. 10.4049/jimmunol.178.5.2623.PubMedCrossRef
6.
go back to reference Akira S: Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 2000, 19 (21): 2607-2611. 10.1038/sj.onc.1203478.PubMedCrossRef Akira S: Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 2000, 19 (21): 2607-2611. 10.1038/sj.onc.1203478.PubMedCrossRef
7.
go back to reference Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoidof Stat3 in macrophages and neutrophils. Immunity. 1999, 10 (1): 39-49. 10.1016/S1074-7613(00)80005-9.PubMedCrossRef Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoidof Stat3 in macrophages and neutrophils. Immunity. 1999, 10 (1): 39-49. 10.1016/S1074-7613(00)80005-9.PubMedCrossRef
8.
go back to reference Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin10. Nat Immunol. 2007, 8 (12): 1363-1371. 10.1038/ni1537.PubMedCrossRef Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin10. Nat Immunol. 2007, 8 (12): 1363-1371. 10.1038/ni1537.PubMedCrossRef
9.
go back to reference Laouar Y, Welte T, Fu XY, Flavell RA: STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity. 2003, 19 (6): 903-912. 10.1016/S1074-7613(03)00332-7.PubMedCrossRef Laouar Y, Welte T, Fu XY, Flavell RA: STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity. 2003, 19 (6): 903-912. 10.1016/S1074-7613(03)00332-7.PubMedCrossRef
10.
go back to reference Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation andintestinal inflammation. J Exp Med. 2001, 193 (4): 471-481. 10.1084/jem.193.4.471.PubMedPubMedCentralCrossRef Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A: CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation andintestinal inflammation. J Exp Med. 2001, 193 (4): 471-481. 10.1084/jem.193.4.471.PubMedPubMedCentralCrossRef
11.
go back to reference Musso A, Dentelli P, Carlino A, Chiusa L, Repici A, Sturm A, Fiocchi C, Rizzetto M, Pegoraro L, Sategna-Guidetti C, Brizzi MF: Signal transducers and activators of transcription 3 signaling pathway: anessential mediator of inflammatory bowel disease and other forms ofintestinal inflammation. Inflamm Bowel Dis. 2005, 11 (2): 91-98. 10.1097/00054725-200502000-00001.PubMedCrossRef Musso A, Dentelli P, Carlino A, Chiusa L, Repici A, Sturm A, Fiocchi C, Rizzetto M, Pegoraro L, Sategna-Guidetti C, Brizzi MF: Signal transducers and activators of transcription 3 signaling pathway: anessential mediator of inflammatory bowel disease and other forms ofintestinal inflammation. Inflamm Bowel Dis. 2005, 11 (2): 91-98. 10.1097/00054725-200502000-00001.PubMedCrossRef
12.
go back to reference Lovato P, Brender C, Agnholt J, Kelsen J, Kaltoft K, Svejgaard A, Eriksen KW, Woetmann A, Ødum N: Constitutive STAT3 activation in intestinal T cells from patients withCrohn's disease. J Biol Chem. 2003, 278 (19): 16777-16781. 10.1074/jbc.M207999200.PubMedCrossRef Lovato P, Brender C, Agnholt J, Kelsen J, Kaltoft K, Svejgaard A, Eriksen KW, Woetmann A, Ødum N: Constitutive STAT3 activation in intestinal T cells from patients withCrohn's disease. J Biol Chem. 2003, 278 (19): 16777-16781. 10.1074/jbc.M207999200.PubMedCrossRef
13.
go back to reference Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ: New insights into the role of STAT3 in IBD. Inflamm Bowel Dis. 2012, 18 (6): 1177-1183. 10.1002/ibd.21884.PubMedCrossRef Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ: New insights into the role of STAT3 in IBD. Inflamm Bowel Dis. 2012, 18 (6): 1177-1183. 10.1002/ibd.21884.PubMedCrossRef
14.
go back to reference Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Genetics Consortium NIDDKIBD, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, et al.: Genome-wide association defines more than 30 distinct susceptibility loci forCrohn's disease. Nat Genet. 2008, 40 (8): 955-962. 10.1038/ng.175.PubMedPubMedCentralCrossRef Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Genetics Consortium NIDDKIBD, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, et al.: Genome-wide association defines more than 30 distinct susceptibility loci forCrohn's disease. Nat Genet. 2008, 40 (8): 955-962. 10.1038/ng.175.PubMedPubMedCentralCrossRef
15.
go back to reference Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, Schuldt D, Nikolaus S, Rosenstiel P, Krawczak M, Schreiber S: Replication of signals from recent studies of Crohn's disease identifiespreviously unknown disease loci for ulcerative colitis. Nat Genet. 2008, 40 (6): 713-715. 10.1038/ng.148.PubMedCrossRef Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, Schuldt D, Nikolaus S, Rosenstiel P, Krawczak M, Schreiber S: Replication of signals from recent studies of Crohn's disease identifiespreviously unknown disease loci for ulcerative colitis. Nat Genet. 2008, 40 (6): 713-715. 10.1038/ng.148.PubMedCrossRef
16.
go back to reference Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K: Strong evidence of a combination polymorphism of the tyrosine kinase 2 geneand the signal transducer and activator of transcription 3 gene as aDNA-based biomarker for susceptibility to Crohn's disease in the Japanesepopulation. J Clin Immunol. 2009, 29 (6): 815-825. 10.1007/s10875-009-9320-x.PubMedPubMedCentralCrossRef Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K: Strong evidence of a combination polymorphism of the tyrosine kinase 2 geneand the signal transducer and activator of transcription 3 gene as aDNA-based biomarker for susceptibility to Crohn's disease in the Japanesepopulation. J Clin Immunol. 2009, 29 (6): 815-825. 10.1007/s10875-009-9320-x.PubMedPubMedCentralCrossRef
17.
go back to reference Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR, Duan H, Karunasinghe N: Genetic factors in chronic inflammation: single nucleotide polymorphisms inthe STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in aNew Zealand population. Mutat Res. 2010, 690 (1–2): 108-115.PubMedCrossRef Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR, Duan H, Karunasinghe N: Genetic factors in chronic inflammation: single nucleotide polymorphisms inthe STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in aNew Zealand population. Mutat Res. 2010, 690 (1–2): 108-115.PubMedCrossRef
18.
go back to reference Cénit MC, Alcina A, Márquez A, Mendoza JL, Díaz-Rubio M, de las Heras V, Izquierdo G, Arroyo R, Fernández O, de la Concha EG, Matesanz F, Urcelay E: STAT3 locus in inflammatory bowel disease and multiple sclerosissusceptibility. Genes Immun. 2010, 11 (3): 264-268. 10.1038/gene.2010.10.PubMedCrossRef Cénit MC, Alcina A, Márquez A, Mendoza JL, Díaz-Rubio M, de las Heras V, Izquierdo G, Arroyo R, Fernández O, de la Concha EG, Matesanz F, Urcelay E: STAT3 locus in inflammatory bowel disease and multiple sclerosissusceptibility. Genes Immun. 2010, 11 (3): 264-268. 10.1038/gene.2010.10.PubMedCrossRef
19.
go back to reference Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ, New York Crohn's Disease Working Group: Evaluation of 22 genetic variants with Crohn's disease risk in the AshkenaziJewish population: a case–control study. BMC Med Genet. 2011, 12: 63-PubMedPubMedCentralCrossRef Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ, New York Crohn's Disease Working Group: Evaluation of 22 genetic variants with Crohn's disease risk in the AshkenaziJewish population: a case–control study. BMC Med Genet. 2011, 12: 63-PubMedPubMedCentralCrossRef
20.
go back to reference Polgar N, Csongei V, Szabo M, Zambo V, Melegh BI, Sumegi K, Nagy G, Tulassay Z, Melegh B: Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-geneinteractions in inflammatory bowel disease. Int J Immunogenet. 2012, 39 (3): 247-252. 10.1111/j.1744-313X.2012.01084.x.PubMedCrossRef Polgar N, Csongei V, Szabo M, Zambo V, Melegh BI, Sumegi K, Nagy G, Tulassay Z, Melegh B: Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-geneinteractions in inflammatory bowel disease. Int J Immunogenet. 2012, 39 (3): 247-252. 10.1111/j.1744-313X.2012.01084.x.PubMedCrossRef
21.
go back to reference Ouyang Q, Tandon R, Goh KL, Pan GZ, Fock KM, Fiocchi C, Lam SK, Xiao SD: Management consensus of inflammatory bowel disease for the Asia-Pacificregion. J Gastroenterol Hepatol. 2006, 21 (12): 1772-1782. 10.1111/j.1440-1746.2006.04674.x.PubMedCrossRef Ouyang Q, Tandon R, Goh KL, Pan GZ, Fock KM, Fiocchi C, Lam SK, Xiao SD: Management consensus of inflammatory bowel disease for the Asia-Pacificregion. J Gastroenterol Hepatol. 2006, 21 (12): 1772-1782. 10.1111/j.1440-1746.2006.04674.x.PubMedCrossRef
22.
go back to reference Matalka II, Al-Omari FA, Salama RM, Mohtaseb AH: A novel approach for quantitative assessment of mucosal damage ininflammatory bowel disease. Diagnostic Pathology. 2013, 8: 156-10.1186/1746-1596-8-156.PubMedPubMedCentralCrossRef Matalka II, Al-Omari FA, Salama RM, Mohtaseb AH: A novel approach for quantitative assessment of mucosal damage ininflammatory bowel disease. Diagnostic Pathology. 2013, 8: 156-10.1186/1746-1596-8-156.PubMedPubMedCentralCrossRef
23.
go back to reference Larsen EP, Bayat A, Vyberg M: Small duct autoimmune sclerosing cholangitis and Crohn colitis in a10-year-old child. A case report and review of the literature. Diagnostic Pathology. 2012, 7: 100-10.1186/1746-1596-7-100.PubMedPubMedCentralCrossRef Larsen EP, Bayat A, Vyberg M: Small duct autoimmune sclerosing cholangitis and Crohn colitis in a10-year-old child. A case report and review of the literature. Diagnostic Pathology. 2012, 7: 100-10.1186/1746-1596-7-100.PubMedPubMedCentralCrossRef
24.
go back to reference Wang ZT, Hu JJ, Fan R, Zhou J, Zhong J: RAGE gene three polymorphisms with Crohn's disease susceptibility in ChineseHan population. World J Gastroenterol. 2014, 20 (9): 2397-2402. 10.3748/wjg.v20.i9.2397.PubMedPubMedCentralCrossRef Wang ZT, Hu JJ, Fan R, Zhou J, Zhong J: RAGE gene three polymorphisms with Crohn's disease susceptibility in ChineseHan population. World J Gastroenterol. 2014, 20 (9): 2397-2402. 10.3748/wjg.v20.i9.2397.PubMedPubMedCentralCrossRef
25.
go back to reference Wang L, Wang ZT, Hu JJ, Fan R, Zhou J, Zhong J: Polymorphisms of the vitamin D receptor gene and the risk of inflammatorybowel disease: a meta-analysis. Genet Mol Res. 2014, 13 (2): 2598-2610. 10.4238/2014.April.8.2.PubMedCrossRef Wang L, Wang ZT, Hu JJ, Fan R, Zhou J, Zhong J: Polymorphisms of the vitamin D receptor gene and the risk of inflammatorybowel disease: a meta-analysis. Genet Mol Res. 2014, 13 (2): 2598-2610. 10.4238/2014.April.8.2.PubMedCrossRef
26.
go back to reference Levy DE, Darnell JJ: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002, 3 (9): 651-662. 10.1038/nrm909.PubMedCrossRef Levy DE, Darnell JJ: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002, 3 (9): 651-662. 10.1038/nrm909.PubMedCrossRef
27.
go back to reference Wang Z, Hu J, Fan R, Zhou J, Zhong J: Association between CD14 gene C-260 T polymorphism and inflammatorybowel disease: a meta-analysis. PLoS One. 2012, 7: e45144-10.1371/journal.pone.0045144.PubMedPubMedCentralCrossRef Wang Z, Hu J, Fan R, Zhou J, Zhong J: Association between CD14 gene C-260 T polymorphism and inflammatorybowel disease: a meta-analysis. PLoS One. 2012, 7: e45144-10.1371/journal.pone.0045144.PubMedPubMedCentralCrossRef
Metadata
Title
Association between STAT3 gene Polymorphisms and Crohn’s diseasesusceptibility: a case–control study in a Chinese Han population
Authors
Zhengting Wang
Bin Xu
Hongxin Zhang
Rong Fan
Jie Zhou
Jie Zhong
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-104

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue